Management of Pediatric Cancer in the COVID-19 ERA
Children with cancer are immunocompromised and are at higher risk of developing serious complications because of infection exposure. During COVID-19 pandemic, many major challenges face pediatric oncologist regarding the continuity of the anticancer therapy, hospital admission, infection protection precautions and expected critical complication post infection in pediatric cancer patients. This raises a question of how to organize pediatric cancer care in the COVID-19 ERA? We propose some critical recommendations focusing primarily on viral infection prevention and control strategies, avoid significant myelosuppression and decreasing the duration of hospitalization or the use of medical resources